Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Onychodystrophy with lichen striatus

M O Goskowicz, L F Eichenfield

    Pediatric Dermatology
    |September 1, 1994
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Estimands for atopic dermatitis clinical trials: Expert opinion on the importance of intercurrent events.

    Journal of the European Academy of Dermatology and Venereology : JEADV·2023
    Same author

    Topical therapy of atopic dermatitis with a focus on pimecrolimus.

    Journal of the European Academy of Dermatology and Venereology : JEADV·2021
    Same author

    Baricitinib improves symptoms in patients with moderate-to-severe atopic dermatitis and inadequate response to topical corticosteroids: patient-reported outcomes from two randomized monotherapy phase III trials.

    The Journal of dermatological treatment·2020
    Same author

    A position paper on the management of itch and pain in atopic dermatitis from the International Society of Atopic Dermatitis (ISAD)/Oriented Patient-Education Network in Dermatology (OPENED) task force.

    Journal of the European Academy of Dermatology and Venereology : JEADV·2020
    Same author

    Dupilumab provides favourable long-term safety and efficacy in children aged ≥ 6 to < 12 years with uncontrolled severe atopic dermatitis: results from an open-label phase IIa study and subsequent phase III open-label extension study.

    The British journal of dermatology·2020
    Same author

    Ustekinumab for the treatment of moderate-to-severe plaque psoriasis in paediatric patients (≥ 6 to < 12 years of age): efficacy, safety, pharmacokinetic and biomarker results from the open-label CADMUS Jr study.

    The British journal of dermatology·2020
    Same journal

    Adverse Childhood Experiences and Pediatric Dermatology: Implications for Care, Equity, and Research.

    Pediatric dermatology·2026
    Same journal

    State-of-the-Art Review: Vaccination in Pediatric Dermatology Patients Receiving Immunosuppressive or Immunomodulatory Therapy: A Review.

    Pediatric dermatology·2026
    Same journal

    Multisystem Mucosal Morbidity in Recessive Dystrophic Epidermolysis Bullosa Inversa.

    Pediatric dermatology·2026
    Same journal

    Infantile Transient Smooth Muscle Contraction of the Skin in Two Sisters.

    Pediatric dermatology·2026
    Same journal

    Are 2021 CMS Changes Enough to Address the Pediatric Dermatology Crisis?

    Pediatric dermatology·2026
    Same journal

    Annular Eruption in 12-Year-Old Boy.

    Pediatric dermatology·2026
    See all related articles